Abstract
Background. Intramedullary spinal cord metastases presenting as the first manifestation of malignancies are extremely rare lesions. Case Description. The authors report a 74-year-old woman who presented with an isolated intramedullary spinal cord metastasis which presents as first manifestation of malignancy without central nervous system and/or other organ involvement. She went under surgery, and after histopathological evaluation, primary focus was determined in lung in positron emission tomography. She is still alive after 9 months since the first diagnosis of primary focus. Conclusion. In patients with solitary intramedullary lesion in the spinal magnetic resonance imaging, whole-body investigation might help for diagnosis of primary focus and approach to treatment.
Highlights
Intramedullary spinal cord metastasis (ISCM) represents 4.2%–8.5% of central nervous system (CNS) and clinically affects only 0.1%–0.4% of all cancer patients [1, 2]
We present a case of a 74-year-old woman with single spinal intramedullary metastasis as the first manifestation of smallcell lung carcinoma
Dam-Hieu et al reported that 42% of patients had systemic and/or CNS metastases at the time of ISCM diagnosis in their study [1]
Summary
Intramedullary spinal cord metastases presenting as the first manifestation of malignancies are extremely rare lesions. The authors report a 74-year-old woman who presented with an isolated intramedullary spinal cord metastasis which presents as first manifestation of malignancy without central nervous system and/or other organ involvement. She went under surgery, and after histopathological evaluation, primary focus was determined in lung in positron emission tomography. After histopathological evaluation, primary focus was determined in lung in positron emission tomography She is still alive after 9 months since the first diagnosis of primary focus. In patients with solitary intramedullary lesion in the spinal magnetic resonance imaging, whole-body investigation might help for diagnosis of primary focus and approach to treatment
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have